We are live on ! Find out more
FBIO icon

Fortress Biotech

77 hedge funds and large institutions have $117M invested in Fortress Biotech in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 14

92% more capital invested

Capital invested by funds: $60.6M → $117M (+$56M)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

5% more funds holding

Funds holding: 7377 (+4)

0.51% more ownership

Funds ownership: 1.83%2.33% (+0.51%)

Holders
77
Holders Change
+4
Holders Change %
+5.48%
% of All Funds
1.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
30
Reduced
14
Closed
10
Calls
Puts
Net Calls
Net Calls Change

FBIO Hedge Fund Activity: Q3 2020 in Review

77 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2020, worth a combined $117M — up 92% from $60.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new FBIO positions and 10 closed out — a net gain of 4 holders — while 30 added to existing stakes and 14 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $12.9M. The largest seller was Renaissance Technologies, cutting an estimated $1.95M.

  • 77 institutional investors held Fortress Biotech (FBIO) as of Q3 2020, up from 73 in Q2 2020.
  • Funds reported $117M of Fortress Biotech stock for Q3 2020, up 92% quarter-over-quarter.
  • 14 funds opened new Fortress Biotech positions in Q3 2020 and 10 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q3 2020 was Nantahala Capital Management, an estimated $12.9M added.
  • The largest Fortress Biotech seller in Q3 2020 was Renaissance Technologies, an estimated $1.95M sold.

Based on aggregated 13F filings for Q3 2020.